Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Catabasis Pharmaceuticals, Inc.
Type
Public
Traded as NASDAQ: CATB
Industry Pharmaceuticals
Headquarters Cambridge, Massachusetts
Key people

Jill C. Milne, Ph.D. (CEO) Joanne M. Donovan, M.D., Ph.D. (Chief Medical Officer and Senior Vice President, Clinical Development) Ted Hibben (Chief Business Officer)

Andrew Nichols, Ph.D. (Chief Scientific Officer)
Products Orally-delivered pharmaceuticals
Number of employees
34 (June 2015)
Website www.catabasis.com

Jill C. Milne, Ph.D. (CEO) Joanne M. Donovan, M.D., Ph.D. (Chief Medical Officer and Senior Vice President, Clinical Development) Ted Hibben (Chief Business Officer)

Catabasis Pharmaceuticals, founded in 2008 and based in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company. Catabasis’ SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables the company to engineer molecules that simultaneously modulate multiple targets in a disease. Catabasis is applying their SMART linker platform to build an internal pipeline of product candidates for rare diseases and plans to pursue partnerships to develop additional product candidates.

Investment goal date:
Dividends reinvested
Catabasis Pharmaceuticals, Inc. CATB report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
A.R.T. Advisors, LLC
46747
Alyeska Investment Group, L.P.
221281
BlackRock Inc.
19656
BOSTON FAMILY OFFICE LLC
24467
BRIDGEWAY CAPITAL MANAGEMENT INC
101347
CITADEL ADVISORS LLC
27944
Clarus Ventures, LLC
2752488
GEODE CAPITAL MANAGEMENT, LLC
33535
GOLDMAN SACHS GROUP INC
19106
OPPENHEIMER & CO INC
90000
RENAISSANCE TECHNOLOGIES LLC
66100
Rhenman & Partners Asset Management AB
310756
SPHERA FUNDS MANAGEMENT LTD.
388030
SV Life Sciences Advisers, LLC
2857667
Vanguard Group, Inc
368893
Major Shareholders
Name Relationship
Total Shares
Holding stocks